Skip to content

Studying the effect of acceptance and commitment based psychotherapy on alexithymia in cancer patients.

Evaluating the Effectiveness of Acceptance and Commitment Therapy (ACT) on Alexithymia and White Blood Cells in Women with Breast Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250706066383N1
Enrollment
42
Registered
2025-12-11
Start date
2025-12-21
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Alexithymia. Condition 2: Alexithymia in Cancer Patients. Condition 3: White Blood Cell Count in Cancer Patients.

Interventions

Intervention 1: This intervention includes a psychotherapy. It is called Psychotherapy for Acceptance and Reception with the acronym. The therapy sessions are held every week and face-to-face. The dur

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Women with breast cancer Age 18 years and above Being in stages one and two of treatment Undergoing chemotherapy No history of psychiatric illness No concurrent physical illness Being literate Fluent in Persian Being mentally healthy Not using drugs

Exclusion criteria

Exclusion criteria: Withdrawal from participation in the study Missing more than two therapy sessions Any drug use during the intervention Use of complementary and alternative medicine methods

Design outcomes

Primary

MeasureTime frame
Alexithymia. Timepoint: Before the intervention, after the end of the intervention and one month after the end of the intervention. Method of measurement: Toronto Alexithymia Scale.;White Blood Cell Count. Timepoint: Before the intervention, after the end of the intervention and one month after the end of the intervention. Method of measurement: Complete Blood Count Blood Test.

Secondary

MeasureTime frame
Alexithymia. Timepoint: At the beginning of the study, at the end of the study, and one month after the study. Method of measurement: Alexithymia Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Tina Vosoughi

Ahvaz Jundishapur university of medical sciences

Vosoughi-t@ajums.ac.ir+98 61 3375 0410

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026